人工智能健康代理:Pathway2vec、ReflectE、范畴理论与长寿

Melanie Swan, Takashi Kido, Eric Roland, Renato P. Dos Santos
{"title":"人工智能健康代理:Pathway2vec、ReflectE、范畴理论与长寿","authors":"Melanie Swan, Takashi Kido, Eric Roland, Renato P. Dos Santos","doi":"10.1609/aaaiss.v3i1.31249","DOIUrl":null,"url":null,"abstract":"Health Agents are introduced as the concept of a personalized AI health advisor overlay for continuous health monitoring (e.g. 1000x/minute) medical-grade smartwatches and wearables for “healthcare by app” instead of “sickcare by appointment.” Individuals can customize the level of detail in the information they view. Health Agents “speak” natural language to humans and formal language to the computational infrastructure, possibly outputting the mathematics of personalized homeostatic health as part of their reinforcement learning agent behavior. As an AI health interface, the agent facilitates the management of precision medicine as a service. Healthy longevity is a high-profile area characterized by the increasing acceptance of medical intervention, longevity biotech venture capital investment, and global priority as 2 billion people will be over 65 in 2050. Aging hallmarks, biomarkers, and clocks provide a quantitative measure for intervention. Some of the leading interventions include metformin, rapamycin, spermidine, NAD+/sirtuins, alpha-ketoglutarate, and taurine. AI-driven digital biology, longevity medicine, and Web3 personalized healthcare come together in the idea of Health Agents. This Web3 genAI tool for automated health management, specifically via digital-biological twins and pathway2vec approaches, demonstrates human-AI intelligence amplification and works towards healthy longevity for global well-being.","PeriodicalId":516827,"journal":{"name":"Proceedings of the AAAI Symposium Series","volume":"33 17","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"AI Health Agents: Pathway2vec, ReflectE, Category Theory, and Longevity\",\"authors\":\"Melanie Swan, Takashi Kido, Eric Roland, Renato P. Dos Santos\",\"doi\":\"10.1609/aaaiss.v3i1.31249\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Health Agents are introduced as the concept of a personalized AI health advisor overlay for continuous health monitoring (e.g. 1000x/minute) medical-grade smartwatches and wearables for “healthcare by app” instead of “sickcare by appointment.” Individuals can customize the level of detail in the information they view. Health Agents “speak” natural language to humans and formal language to the computational infrastructure, possibly outputting the mathematics of personalized homeostatic health as part of their reinforcement learning agent behavior. As an AI health interface, the agent facilitates the management of precision medicine as a service. Healthy longevity is a high-profile area characterized by the increasing acceptance of medical intervention, longevity biotech venture capital investment, and global priority as 2 billion people will be over 65 in 2050. Aging hallmarks, biomarkers, and clocks provide a quantitative measure for intervention. Some of the leading interventions include metformin, rapamycin, spermidine, NAD+/sirtuins, alpha-ketoglutarate, and taurine. AI-driven digital biology, longevity medicine, and Web3 personalized healthcare come together in the idea of Health Agents. This Web3 genAI tool for automated health management, specifically via digital-biological twins and pathway2vec approaches, demonstrates human-AI intelligence amplification and works towards healthy longevity for global well-being.\",\"PeriodicalId\":516827,\"journal\":{\"name\":\"Proceedings of the AAAI Symposium Series\",\"volume\":\"33 17\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings of the AAAI Symposium Series\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1609/aaaiss.v3i1.31249\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the AAAI Symposium Series","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1609/aaaiss.v3i1.31249","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

健康代理的概念是为医疗级智能手表和可穿戴设备提供个性化的人工智能健康顾问,用于持续监测健康状况(例如 1000 倍/分钟),实现 "应用医疗 "而非 "预约医疗"。个人可以自定义查看信息的详细程度。健康代理对人类 "讲 "自然语言,对计算基础设施 "讲 "形式语言,并可能输出个性化同态健康数学,作为其强化学习代理行为的一部分。作为人工智能健康界面,该代理有助于将精准医疗作为一种服务进行管理。健康长寿是一个备受瞩目的领域,其特点是人们越来越多地接受医疗干预、长寿生物技术风险投资和全球优先事项,因为 2050 年将有 20 亿人超过 65 岁。衰老标志、生物标志物和时钟为干预提供了量化指标。一些主要的干预措施包括二甲双胍、雷帕霉素、亚精胺、NAD+/酪蛋白、α-酮戊二酸和牛磺酸。人工智能驱动的数字生物学、长寿医学和 Web3 个性化医疗保健在 "健康代理"(Health Agents)这一理念中融为一体。这种用于自动健康管理的 Web3 genAI 工具,特别是通过数字生物双胞胎和 pathway2vec 方法,展示了人类-人工智能的智能放大,并致力于实现健康长寿,促进全球福祉。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
AI Health Agents: Pathway2vec, ReflectE, Category Theory, and Longevity
Health Agents are introduced as the concept of a personalized AI health advisor overlay for continuous health monitoring (e.g. 1000x/minute) medical-grade smartwatches and wearables for “healthcare by app” instead of “sickcare by appointment.” Individuals can customize the level of detail in the information they view. Health Agents “speak” natural language to humans and formal language to the computational infrastructure, possibly outputting the mathematics of personalized homeostatic health as part of their reinforcement learning agent behavior. As an AI health interface, the agent facilitates the management of precision medicine as a service. Healthy longevity is a high-profile area characterized by the increasing acceptance of medical intervention, longevity biotech venture capital investment, and global priority as 2 billion people will be over 65 in 2050. Aging hallmarks, biomarkers, and clocks provide a quantitative measure for intervention. Some of the leading interventions include metformin, rapamycin, spermidine, NAD+/sirtuins, alpha-ketoglutarate, and taurine. AI-driven digital biology, longevity medicine, and Web3 personalized healthcare come together in the idea of Health Agents. This Web3 genAI tool for automated health management, specifically via digital-biological twins and pathway2vec approaches, demonstrates human-AI intelligence amplification and works towards healthy longevity for global well-being.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信